Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice

When are pro-inflammatory cytokines SAFE in heart failure?

(2011) S. Lecour et al.   EUROPEAN HEART JOURNAL

Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction

(2011) Junichi Matsubara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Therapeutic Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-11 Ameliorates Cardiac Fibrosis After Myocardial Infarction

(2010) Masanori Obana et al.   CIRCULATION

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction

(2010) Donald M. Lloyd-Jones et al.   CIRCULATION

Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers

(2010) L. Tamariz et al.   EUROPEAN HEART JOURNAL

Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis

(2010) A. T. Yan et al.   EUROPEAN HEART JOURNAL

Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats

(2010) Giselle C. Meléndez et al.   HYPERTENSION

Adenylyl Cyclase 6 Deletion Reduces Left Ventricular Hypertrophy, Dilation, Dysfunction, and Fibrosis in Pressure-Overloaded Female Mice

(2010) Tong Tang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inflammatory Markers and Incident Heart Failure Risk in Older Adults

(2010) Andreas Kalogeropoulos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biomarkers of inflammation in heart failure

(2009) Biykem Bozkurt et al.   HEART FAILURE REVIEWS